Log in

NYSE:RUBIThe Rubicon Project Competitors & Alternatives

$6.81
+0.16 (+2.41 %)
(As of 07/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$6.61
Now: $6.81
$7.03
50-Day Range
$5.08
MA: $6.63
$8.28
52-Week Range
$4.09
Now: $6.81
$13.11
Volume2.32 million shs
Average Volume2.34 million shs
Market Capitalization$730.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.64

Competitors

The Rubicon Project (NYSE:RUBI) Vs. PS, TRIP, SABR, CDLX, MODN, and HCAT

Should you be buying RUBI stock or one of its competitors? Companies in the industry of "computer programming, data processing, & other computer related" are considered alternatives and competitors to The Rubicon Project, including Pluralsight (PS), Tripadvisor (TRIP), Sabre (SABR), Cardlytics (CDLX), Model N (MODN), and Health Catalyst (HCAT).

Pluralsight (NASDAQ:PS) and The Rubicon Project (NYSE:RUBI) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership.

Profitability

This table compares Pluralsight and The Rubicon Project's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pluralsight-38.07%-54.65%-13.47%
The Rubicon Project-14.10%-14.34%-4.36%

Insider and Institutional Ownership

83.8% of Pluralsight shares are held by institutional investors. Comparatively, 40.7% of The Rubicon Project shares are held by institutional investors. 21.8% of Pluralsight shares are held by insiders. Comparatively, 5.7% of The Rubicon Project shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Pluralsight and The Rubicon Project, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pluralsight021002.83
The Rubicon Project00403.00

Pluralsight presently has a consensus price target of $21.50, indicating a potential upside of 12.98%. The Rubicon Project has a consensus price target of $9.3750, indicating a potential upside of 37.67%. Given The Rubicon Project's stronger consensus rating and higher possible upside, analysts clearly believe The Rubicon Project is more favorable than Pluralsight.

Risk & Volatility

Pluralsight has a beta of 2.63, suggesting that its share price is 163% more volatile than the S&P 500. Comparatively, The Rubicon Project has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500.

Earnings & Valuation

This table compares Pluralsight and The Rubicon Project's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pluralsight$316.91 million8.58$-112,660,000.00($0.98)-19.42
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41

The Rubicon Project has lower revenue, but higher earnings than Pluralsight. Pluralsight is trading at a lower price-to-earnings ratio than The Rubicon Project, indicating that it is currently the more affordable of the two stocks.

Summary

The Rubicon Project beats Pluralsight on 8 of the 14 factors compared between the two stocks.

The Rubicon Project (NYSE:RUBI) and Tripadvisor (NASDAQ:TRIP) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Profitability

This table compares The Rubicon Project and Tripadvisor's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Rubicon Project-14.10%-14.34%-4.36%
Tripadvisor5.67%7.82%4.48%

Insider & Institutional Ownership

40.7% of The Rubicon Project shares are owned by institutional investors. Comparatively, 72.5% of Tripadvisor shares are owned by institutional investors. 5.7% of The Rubicon Project shares are owned by insiders. Comparatively, 3.8% of Tripadvisor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for The Rubicon Project and Tripadvisor, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Rubicon Project00403.00
Tripadvisor416502.04

The Rubicon Project currently has a consensus target price of $9.3750, indicating a potential upside of 37.67%. Tripadvisor has a consensus target price of $27.0455, indicating a potential upside of 38.62%. Given Tripadvisor's higher possible upside, analysts clearly believe Tripadvisor is more favorable than The Rubicon Project.

Risk & Volatility

The Rubicon Project has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Tripadvisor has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500.

Valuation & Earnings

This table compares The Rubicon Project and Tripadvisor's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41
Tripadvisor$1.56 billion1.68$126 million$1.0818.06

Tripadvisor has higher revenue and earnings than The Rubicon Project. The Rubicon Project is trading at a lower price-to-earnings ratio than Tripadvisor, indicating that it is currently the more affordable of the two stocks.

Summary

Tripadvisor beats The Rubicon Project on 10 of the 14 factors compared between the two stocks.

The Rubicon Project (NYSE:RUBI) and Sabre (NASDAQ:SABR) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Profitability

This table compares The Rubicon Project and Sabre's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Rubicon Project-14.10%-14.34%-4.36%
Sabre-3.09%5.38%0.82%

Insider & Institutional Ownership

40.7% of The Rubicon Project shares are owned by institutional investors. Comparatively, 91.7% of Sabre shares are owned by institutional investors. 5.7% of The Rubicon Project shares are owned by insiders. Comparatively, 0.7% of Sabre shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for The Rubicon Project and Sabre, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Rubicon Project00403.00
Sabre14202.14

The Rubicon Project currently has a consensus target price of $9.3750, indicating a potential upside of 37.67%. Sabre has a consensus target price of $12.75, indicating a potential upside of 57.21%. Given Sabre's higher possible upside, analysts clearly believe Sabre is more favorable than The Rubicon Project.

Risk & Volatility

The Rubicon Project has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Sabre has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500.

Valuation & Earnings

This table compares The Rubicon Project and Sabre's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41
Sabre$3.97 billion0.56$158.59 million$0.839.77

Sabre has higher revenue and earnings than The Rubicon Project. The Rubicon Project is trading at a lower price-to-earnings ratio than Sabre, indicating that it is currently the more affordable of the two stocks.

Summary

Sabre beats The Rubicon Project on 9 of the 14 factors compared between the two stocks.

Cardlytics (NASDAQ:CDLX) and The Rubicon Project (NYSE:RUBI) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.

Earnings & Valuation

This table compares Cardlytics and The Rubicon Project's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardlytics$210.43 million9.15$-17,140,000.00($0.75)-95.15
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41

Cardlytics has higher revenue and earnings than The Rubicon Project. Cardlytics is trading at a lower price-to-earnings ratio than The Rubicon Project, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Cardlytics and The Rubicon Project, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cardlytics13202.17
The Rubicon Project00403.00

Cardlytics currently has a consensus target price of $48.50, indicating a potential downside of 32.03%. The Rubicon Project has a consensus target price of $9.3750, indicating a potential upside of 37.67%. Given The Rubicon Project's stronger consensus rating and higher probable upside, analysts plainly believe The Rubicon Project is more favorable than Cardlytics.

Institutional & Insider Ownership

83.5% of Cardlytics shares are owned by institutional investors. Comparatively, 40.7% of The Rubicon Project shares are owned by institutional investors. 6.5% of Cardlytics shares are owned by company insiders. Comparatively, 5.7% of The Rubicon Project shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Cardlytics has a beta of 2.54, meaning that its share price is 154% more volatile than the S&P 500. Comparatively, The Rubicon Project has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.

Profitability

This table compares Cardlytics and The Rubicon Project's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cardlytics-11.08%-19.42%-11.53%
The Rubicon Project-14.10%-14.34%-4.36%

Model N (NYSE:MODN) and The Rubicon Project (NYSE:RUBI) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.

Profitability

This table compares Model N and The Rubicon Project's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Model N-10.88%-19.69%-6.54%
The Rubicon Project-14.10%-14.34%-4.36%

Earnings & Valuation

This table compares Model N and The Rubicon Project's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Model N$141.24 million9.40$-19,290,000.00($0.43)-90.09
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41

Model N has higher earnings, but lower revenue than The Rubicon Project. Model N is trading at a lower price-to-earnings ratio than The Rubicon Project, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Model N and The Rubicon Project, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Model N01702.88
The Rubicon Project00403.00

Model N currently has a consensus target price of $33.2857, indicating a potential downside of 14.08%. The Rubicon Project has a consensus target price of $9.3750, indicating a potential upside of 37.67%. Given The Rubicon Project's stronger consensus rating and higher probable upside, analysts plainly believe The Rubicon Project is more favorable than Model N.

Volatility and Risk

Model N has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, The Rubicon Project has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.

Institutional & Insider Ownership

81.4% of Model N shares are owned by institutional investors. Comparatively, 40.7% of The Rubicon Project shares are owned by institutional investors. 1.6% of Model N shares are owned by company insiders. Comparatively, 5.7% of The Rubicon Project shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

The Rubicon Project beats Model N on 9 of the 14 factors compared between the two stocks.

Health Catalyst (NASDAQ:HCAT) and The Rubicon Project (NYSE:RUBI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk.

Profitability

This table compares Health Catalyst and The Rubicon Project's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Health Catalyst-38.74%30.42%19.97%
The Rubicon Project-14.10%-14.34%-4.36%

Valuation & Earnings

This table compares Health Catalyst and The Rubicon Project's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$154.94 million7.73$-60,100,000.00($1.42)-22.19
The Rubicon Project$156.41 million4.67$-25,480,000.00($0.37)-18.41

The Rubicon Project has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than The Rubicon Project, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings for Health Catalyst and The Rubicon Project, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Health Catalyst001213.08
The Rubicon Project00403.00

Health Catalyst currently has a consensus price target of $40.9167, indicating a potential upside of 29.85%. The Rubicon Project has a consensus price target of $9.3750, indicating a potential upside of 37.67%. Given The Rubicon Project's higher probable upside, analysts clearly believe The Rubicon Project is more favorable than Health Catalyst.

Insider and Institutional Ownership

71.2% of Health Catalyst shares are owned by institutional investors. Comparatively, 40.7% of The Rubicon Project shares are owned by institutional investors. 22.1% of Health Catalyst shares are owned by company insiders. Comparatively, 5.7% of The Rubicon Project shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Health Catalyst beats The Rubicon Project on 9 of the 14 factors compared between the two stocks.

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Pluralsight logo
PS
Pluralsight
1.5$19.03+1.1%$2.72 billion$316.91 million-15.99Decrease in Short Interest
Tripadvisor logo
TRIP
Tripadvisor
1.7$19.51+2.1%$2.62 billion$1.56 billion33.07
Sabre logo
SABR
Sabre
2.3$8.11+0.6%$2.22 billion$3.97 billion-19.78
Cardlytics logo
CDLX
Cardlytics
1.2$71.36+5.4%$1.82 billion$210.43 million-70.65Insider Selling
Heavy News Reporting
Model N logo
MODN
Model N
1.3$38.74+1.4%$1.31 billion$141.24 million-79.06Heavy News Reporting
HCAT
Health Catalyst
1.8$31.51+4.8%$1.14 billion$154.94 million-5.97Insider Selling
Heavy News Reporting
QTT
Qutoutiao
0.9$4.19+17.4%$980.15 million$790.85 million-3.01Analyst Upgrade
High Trading Volume
Decrease in Short Interest
Heavy News Reporting
Eventbrite logo
EB
Eventbrite
1.4$8.32+2.8%$744.96 million$326.80 million-3.45
HealthStream logo
HSTM
HealthStream
1.2$21.97+0.1%$702.98 million$254.11 million43.08Decrease in Short Interest
PVT
Pivotal Acquisition
1.0$9.90+0.0%$284.63 million$312.05 million-7.80High Trading Volume
TrueCar logo
TRUE
TrueCar
1.4$2.80+8.6%$274.61 million$353.88 million-5.83
LIZI
Phoenix Tree
1.5$5.28+1.5%$241.47 million$169.58 million0.00
JG
Aurora Mobile
0.5$1.55+3.2%$179.45 million$130.21 million-9.12
Jianpu Technology logo
JT
Jianpu Technology
0.7$0.63+1.6%$108.96 million$234.18 million-2.12Decrease in Short Interest
Synacor logo
SYNC
Synacor
0.5$1.11+1.8%$44.58 million$121.85 million-3.96Decrease in Short Interest
PT
Pintec Technology
0.6$1.12+14.3%$41.95 million$184.61 million0.00
GIGM
GigaMedia
1.2$3.03+2.0%$33.49 million$6.64 million-25.25Increase in Short Interest
Sify Technologies logo
SIFY
Sify Technologies
2.2$0.80+0.9%$32.37 million$326.31 million0.00
Professional Diversity Network logo
IPDN
Professional Diversity Network
0.4$2.33+23.6%$31.47 million$5.03 million0.00
CNET
Chinanet Online
0.5$1.04+1.9%$22.56 million$58.08 million-9.45Decrease in Short Interest
Autoweb logo
AUTO
Autoweb
1.6$1.20+1.7%$15.78 million$113.98 million-1.13Heavy News Reporting
MOXC
Lianluo Smart
0.3$0.87+10.3%$12.63 million$370,000.0087.08Increase in Short Interest
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.